Impaired filterability of erythrocytes from patients with chronic hepatitis C and effects of eicosapentaenoic acid on the filterability

Ritsuko Seki, Takashi Okamura, Tatsuya Ide, Masayoshi Kage, Michio Sata, Nobuhiro Uyesaka, Toru Maruyama

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Although erythrocyte filterability plays a key role in microcirculation, it is unknown whether the filterability of erythrocytes from patients with chronic hepatitis C (CH-C) is impaired. This study aimed to investigate erythrocyte filterability in CH-C patients in relation to medical treatment. The mean erythrocyte filterability (%) for all 24 patients with CH-C (69.2 ± 10.8%) was significantly lower than that for 5 normal controls (80.5 ± 1.7%, P < 0.03). In 8 patients, the combination therapy of ribavirin (RBV) and interferon improved liver function but caused anemia. The filterability after treatment (57.8 ± 12.8%) was lower than that before treatment (70.8 ± 9.7%, P < 0.05). Decreased filterability showed no correlation with the mean corpuscular volume or mean corpuscular Hb concentration during treatment, suggesting that the decrease in filterability mainly arises from changes in erythrocyte membrane properties. We investigated the protective effects of eicosapentaenoic acid (EPA) on the RBV-induced anemia. Filterability in 7 responders was markedly improved from 68.4 ± 4.6% to 77.4 ± 2.4% (P < 0.001), but not in 3 nonresponders. In the responders, the progression of anemia was restrained. In conclusion, we found an obvious impairment of the filterability of erythrocytes from CH-C patients, further impairment of the filterability induced by oxidative membrane damage caused by RBV leading to hemolytic anemia, and amelioration of the filterability caused by the antioxidative effects of EPA.

Original languageEnglish
Pages (from-to)43-49
Number of pages7
JournalJournal of Physiological Sciences
Volume57
Issue number1
DOIs
Publication statusPublished - Feb 1 2007

Fingerprint

Erythrocyte Deformability
Eicosapentaenoic Acid
Chronic Hepatitis C
Ribavirin
Anemia
Therapeutics
Erythrocyte Indices
Hemolytic Anemia
Erythrocyte Membrane
Microcirculation
Interferons
Membranes
Liver

All Science Journal Classification (ASJC) codes

  • Physiology

Cite this

Impaired filterability of erythrocytes from patients with chronic hepatitis C and effects of eicosapentaenoic acid on the filterability. / Seki, Ritsuko; Okamura, Takashi; Ide, Tatsuya; Kage, Masayoshi; Sata, Michio; Uyesaka, Nobuhiro; Maruyama, Toru.

In: Journal of Physiological Sciences, Vol. 57, No. 1, 01.02.2007, p. 43-49.

Research output: Contribution to journalArticle

Seki, Ritsuko ; Okamura, Takashi ; Ide, Tatsuya ; Kage, Masayoshi ; Sata, Michio ; Uyesaka, Nobuhiro ; Maruyama, Toru. / Impaired filterability of erythrocytes from patients with chronic hepatitis C and effects of eicosapentaenoic acid on the filterability. In: Journal of Physiological Sciences. 2007 ; Vol. 57, No. 1. pp. 43-49.
@article{1faea0d66a334afbbeb0895c05f67304,
title = "Impaired filterability of erythrocytes from patients with chronic hepatitis C and effects of eicosapentaenoic acid on the filterability",
abstract = "Although erythrocyte filterability plays a key role in microcirculation, it is unknown whether the filterability of erythrocytes from patients with chronic hepatitis C (CH-C) is impaired. This study aimed to investigate erythrocyte filterability in CH-C patients in relation to medical treatment. The mean erythrocyte filterability ({\%}) for all 24 patients with CH-C (69.2 ± 10.8{\%}) was significantly lower than that for 5 normal controls (80.5 ± 1.7{\%}, P < 0.03). In 8 patients, the combination therapy of ribavirin (RBV) and interferon improved liver function but caused anemia. The filterability after treatment (57.8 ± 12.8{\%}) was lower than that before treatment (70.8 ± 9.7{\%}, P < 0.05). Decreased filterability showed no correlation with the mean corpuscular volume or mean corpuscular Hb concentration during treatment, suggesting that the decrease in filterability mainly arises from changes in erythrocyte membrane properties. We investigated the protective effects of eicosapentaenoic acid (EPA) on the RBV-induced anemia. Filterability in 7 responders was markedly improved from 68.4 ± 4.6{\%} to 77.4 ± 2.4{\%} (P < 0.001), but not in 3 nonresponders. In the responders, the progression of anemia was restrained. In conclusion, we found an obvious impairment of the filterability of erythrocytes from CH-C patients, further impairment of the filterability induced by oxidative membrane damage caused by RBV leading to hemolytic anemia, and amelioration of the filterability caused by the antioxidative effects of EPA.",
author = "Ritsuko Seki and Takashi Okamura and Tatsuya Ide and Masayoshi Kage and Michio Sata and Nobuhiro Uyesaka and Toru Maruyama",
year = "2007",
month = "2",
day = "1",
doi = "10.2170/physiolsci.RP010506",
language = "English",
volume = "57",
pages = "43--49",
journal = "Journal of Physiological Sciences",
issn = "1880-6546",
publisher = "Springer Japan",
number = "1",

}

TY - JOUR

T1 - Impaired filterability of erythrocytes from patients with chronic hepatitis C and effects of eicosapentaenoic acid on the filterability

AU - Seki, Ritsuko

AU - Okamura, Takashi

AU - Ide, Tatsuya

AU - Kage, Masayoshi

AU - Sata, Michio

AU - Uyesaka, Nobuhiro

AU - Maruyama, Toru

PY - 2007/2/1

Y1 - 2007/2/1

N2 - Although erythrocyte filterability plays a key role in microcirculation, it is unknown whether the filterability of erythrocytes from patients with chronic hepatitis C (CH-C) is impaired. This study aimed to investigate erythrocyte filterability in CH-C patients in relation to medical treatment. The mean erythrocyte filterability (%) for all 24 patients with CH-C (69.2 ± 10.8%) was significantly lower than that for 5 normal controls (80.5 ± 1.7%, P < 0.03). In 8 patients, the combination therapy of ribavirin (RBV) and interferon improved liver function but caused anemia. The filterability after treatment (57.8 ± 12.8%) was lower than that before treatment (70.8 ± 9.7%, P < 0.05). Decreased filterability showed no correlation with the mean corpuscular volume or mean corpuscular Hb concentration during treatment, suggesting that the decrease in filterability mainly arises from changes in erythrocyte membrane properties. We investigated the protective effects of eicosapentaenoic acid (EPA) on the RBV-induced anemia. Filterability in 7 responders was markedly improved from 68.4 ± 4.6% to 77.4 ± 2.4% (P < 0.001), but not in 3 nonresponders. In the responders, the progression of anemia was restrained. In conclusion, we found an obvious impairment of the filterability of erythrocytes from CH-C patients, further impairment of the filterability induced by oxidative membrane damage caused by RBV leading to hemolytic anemia, and amelioration of the filterability caused by the antioxidative effects of EPA.

AB - Although erythrocyte filterability plays a key role in microcirculation, it is unknown whether the filterability of erythrocytes from patients with chronic hepatitis C (CH-C) is impaired. This study aimed to investigate erythrocyte filterability in CH-C patients in relation to medical treatment. The mean erythrocyte filterability (%) for all 24 patients with CH-C (69.2 ± 10.8%) was significantly lower than that for 5 normal controls (80.5 ± 1.7%, P < 0.03). In 8 patients, the combination therapy of ribavirin (RBV) and interferon improved liver function but caused anemia. The filterability after treatment (57.8 ± 12.8%) was lower than that before treatment (70.8 ± 9.7%, P < 0.05). Decreased filterability showed no correlation with the mean corpuscular volume or mean corpuscular Hb concentration during treatment, suggesting that the decrease in filterability mainly arises from changes in erythrocyte membrane properties. We investigated the protective effects of eicosapentaenoic acid (EPA) on the RBV-induced anemia. Filterability in 7 responders was markedly improved from 68.4 ± 4.6% to 77.4 ± 2.4% (P < 0.001), but not in 3 nonresponders. In the responders, the progression of anemia was restrained. In conclusion, we found an obvious impairment of the filterability of erythrocytes from CH-C patients, further impairment of the filterability induced by oxidative membrane damage caused by RBV leading to hemolytic anemia, and amelioration of the filterability caused by the antioxidative effects of EPA.

UR - http://www.scopus.com/inward/record.url?scp=34248198540&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34248198540&partnerID=8YFLogxK

U2 - 10.2170/physiolsci.RP010506

DO - 10.2170/physiolsci.RP010506

M3 - Article

C2 - 17204208

AN - SCOPUS:34248198540

VL - 57

SP - 43

EP - 49

JO - Journal of Physiological Sciences

JF - Journal of Physiological Sciences

SN - 1880-6546

IS - 1

ER -